IL157358A0 - Pharmaceutical compositions containing a retinoid receptor ligand and a cytotoxic agent - Google Patents
Pharmaceutical compositions containing a retinoid receptor ligand and a cytotoxic agentInfo
- Publication number
- IL157358A0 IL157358A0 IL15735802A IL15735802A IL157358A0 IL 157358 A0 IL157358 A0 IL 157358A0 IL 15735802 A IL15735802 A IL 15735802A IL 15735802 A IL15735802 A IL 15735802A IL 157358 A0 IL157358 A0 IL 157358A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- cytotoxic agent
- receptor ligand
- retinoid receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27775401P | 2001-03-22 | 2001-03-22 | |
| PCT/US2002/008718 WO2002078620A2 (en) | 2001-03-22 | 2002-03-22 | Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL157358A0 true IL157358A0 (en) | 2004-02-19 |
Family
ID=23062213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15735802A IL157358A0 (en) | 2001-03-22 | 2002-03-22 | Pharmaceutical compositions containing a retinoid receptor ligand and a cytotoxic agent |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1383491A2 (https=) |
| JP (1) | JP2004528316A (https=) |
| KR (1) | KR20030086314A (https=) |
| CN (1) | CN1498105A (https=) |
| BR (1) | BR0207681A (https=) |
| CA (1) | CA2441335A1 (https=) |
| CZ (1) | CZ20032540A3 (https=) |
| DE (1) | DE02733871T1 (https=) |
| ES (1) | ES2214985T1 (https=) |
| HU (1) | HUP0400255A2 (https=) |
| IL (1) | IL157358A0 (https=) |
| MX (1) | MXPA03008403A (https=) |
| PL (1) | PL368946A1 (https=) |
| TR (1) | TR200400812T3 (https=) |
| WO (1) | WO2002078620A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5113038B2 (ja) * | 2006-03-23 | 2013-01-09 | テムリック株式会社 | 癌治療用キットおよび癌治療用医薬組成物 |
-
2002
- 2002-03-22 WO PCT/US2002/008718 patent/WO2002078620A2/en not_active Ceased
- 2002-03-22 TR TR2004/00812T patent/TR200400812T3/xx unknown
- 2002-03-22 CA CA002441335A patent/CA2441335A1/en not_active Abandoned
- 2002-03-22 IL IL15735802A patent/IL157358A0/xx unknown
- 2002-03-22 DE DE0001383491T patent/DE02733871T1/de active Pending
- 2002-03-22 JP JP2002576888A patent/JP2004528316A/ja not_active Withdrawn
- 2002-03-22 PL PL02368946A patent/PL368946A1/xx not_active Application Discontinuation
- 2002-03-22 HU HU0400255A patent/HUP0400255A2/hu unknown
- 2002-03-22 ES ES02733871T patent/ES2214985T1/es active Pending
- 2002-03-22 BR BR0207681-0A patent/BR0207681A/pt not_active Application Discontinuation
- 2002-03-22 MX MXPA03008403A patent/MXPA03008403A/es unknown
- 2002-03-22 CN CNA028070011A patent/CN1498105A/zh active Pending
- 2002-03-22 KR KR10-2003-7012217A patent/KR20030086314A/ko not_active Withdrawn
- 2002-03-22 EP EP02733871A patent/EP1383491A2/en not_active Withdrawn
- 2002-03-22 CZ CZ20032540A patent/CZ20032540A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1498105A (zh) | 2004-05-19 |
| PL368946A1 (pl) | 2005-04-04 |
| BR0207681A (pt) | 2004-07-27 |
| HUP0400255A2 (hu) | 2004-08-30 |
| KR20030086314A (ko) | 2003-11-07 |
| DE02733871T1 (de) | 2004-08-26 |
| TR200400812T3 (tr) | 2004-07-21 |
| ES2214985T1 (es) | 2004-10-01 |
| JP2004528316A (ja) | 2004-09-16 |
| WO2002078620A2 (en) | 2002-10-10 |
| CA2441335A1 (en) | 2002-10-10 |
| CZ20032540A3 (cs) | 2004-05-12 |
| WO2002078620A3 (en) | 2003-04-17 |
| MXPA03008403A (es) | 2004-01-29 |
| EP1383491A2 (en) | 2004-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301777A3 (en) | Aniline-derived ligands for the thyroid receptor, pharmaceutical compositions comprising thereof and their use | |
| HUP0204372A3 (en) | Pharmaceutical compositions providing enhanced drug concentrations | |
| HUP0203965A3 (en) | Indazole compounds and pharmaceutical compositions containing them | |
| HUP0400251A3 (en) | 5-ht receptor ligands and uses thereof and pharmaceutical compositions containing them | |
| HUS1400025I1 (hu) | Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek | |
| HUP0401924A3 (en) | Cannabinoid receptor ligands, their use and pharmaceutical compositions containing them | |
| HUP0304060A3 (en) | Cannabinoid receptor ligands, their use and pharmaceutical compositions containing them | |
| HUP0400052A3 (en) | Carboxamide-substituted phenylurea derivatives and pharmaceutical compositions containing them and their use | |
| IL157741A0 (en) | Pharmaceutical compositions containing an antihyperplastic active agent | |
| HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
| SI1381346T1 (sl) | Farmacevtski sestavki, ki vsebujejo formoterol | |
| HUP0303325A3 (en) | Pharmaceutical salts and pharmaceutical compositions containing them | |
| IL145177A0 (en) | A pharmaceutical composition containing xenon | |
| HUP0202495A3 (en) | Stable medicinal compositions for oral use | |
| HUP0401333A3 (en) | Spiropyrazole compounds and pharmaceutical compositions containing them | |
| IL145290A0 (en) | Pharmaceutical compositions comprising complexes | |
| IL150383A0 (en) | Glyburide and pharmaceutical compositions containing the same | |
| HUP0400644A3 (en) | Pharmaceutical compositions containing aspirin | |
| AU2003276549A8 (en) | Pharmaceutical compositions containing a biguanide-glitazone combination | |
| AU2002217464A1 (en) | Medicinal compositions containing aspirin | |
| HUP0400850A3 (en) | Oral pharmaceutical compositions | |
| HUP0105204A3 (en) | Substituted phenethylamine derivatives and pharmaceutical compositions containing them | |
| IL151910A0 (en) | Compositions for drug delivery | |
| HUP0103924A3 (en) | Oral pharmaceutical compositions containing buprenorphin | |
| HUP0301390A3 (en) | Oral pharmaceutical composition containing valsartan |